Norges Bank
VRTX icon

Norges Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.59B Buy
+3,580,356
New +$1.59B 0.2% 94
2025
Q1
Sell
-3,414,324
Closed -$1.37B 1647
2024
Q4
$1.37B Buy
+3,414,324
New +$1.37B 0.18% 98
2024
Q3
Sell
-3,429,086
Closed -$1.61B 1726
2024
Q2
$1.61B Sell
3,429,086
-28,864
-0.8% -$13.5M 0.24% 72
2024
Q1
$1.45B Buy
3,457,950
+415,662
+14% +$174M 0.23% 78
2023
Q4
$1.24B Buy
3,042,288
+368,382
+14% +$150M 0.22% 86
2023
Q3
$930M Buy
2,673,906
+64,995
+2% +$22.6M 0.19% 106
2023
Q2
$918M Buy
2,608,911
+79,972
+3% +$28.1M 0.18% 106
2023
Q1
$797M Buy
2,528,939
+77,418
+3% +$24.4M 0.17% 114
2022
Q4
$708M Buy
2,451,521
+163,049
+7% +$47.1M 0.17% 121
2022
Q3
$663M Buy
2,288,472
+61,874
+3% +$17.9M 0.18% 105
2022
Q2
$627M Sell
2,226,598
-398,150
-15% -$112M 0.16% 121
2022
Q1
$685M Sell
2,624,748
-55,151
-2% -$14.4M 0.15% 134
2021
Q4
$589M Buy
2,679,899
+153,719
+6% +$33.8M 0.12% 159
2021
Q3
$458M Sell
2,526,180
-21,250
-0.8% -$3.85M 0.1% 193
2021
Q2
$514M Sell
2,547,430
-90,096
-3% -$18.2M 0.11% 176
2021
Q1
$567M Sell
2,637,526
-133,800
-5% -$28.8M 0.13% 158
2020
Q4
$655M Sell
2,771,326
-90,928
-3% -$21.5M 0.15% 126
2020
Q3
$779M Buy
2,862,254
+175,851
+7% +$47.9M 0.21% 85
2020
Q2
$780M Buy
2,686,403
+148,490
+6% +$43.1M 0.22% 76
2020
Q1
$604M Buy
2,537,913
+20,310
+0.8% +$4.83M 0.22% 86
2019
Q4
$551M Buy
2,517,603
+135,224
+6% +$29.6M 0.15% 128
2019
Q3
$404M Hold
2,382,379
0.12% 165
2019
Q2
$437M Hold
2,382,379
0.14% 149
2019
Q1
$438M Buy
2,382,379
+85,698
+4% +$15.8M 0.14% 138
2018
Q4
$381M Sell
2,296,681
-27,323
-1% -$4.53M 0.14% 137
2018
Q3
$448M Sell
2,324,004
-41,203
-2% -$7.94M 0.15% 138
2018
Q2
$402M Sell
2,365,207
-69,449
-3% -$11.8M 0.14% 148
2018
Q1
$397M Buy
2,434,656
+94,152
+4% +$15.3M 0.14% 142
2017
Q4
$351M Buy
2,340,504
+191,180
+9% +$28.7M 0.13% 166
2017
Q3
$327M Buy
2,149,324
+125,272
+6% +$19M 0.12% 169
2017
Q2
$261M Sell
2,024,052
-127,869
-6% -$16.5M 0.1% 211
2017
Q1
$235M Buy
2,151,921
+420,366
+24% +$46M 0.1% 215
2016
Q4
$128M Buy
1,731,555
+56,502
+3% +$4.16M 0.06% 333
2016
Q3
$140M Hold
1,675,053
0.07% 284
2016
Q2
$144M Sell
1,675,053
-45,441
-3% -$3.91M 0.07% 282
2016
Q1
$137M Sell
1,720,494
-53,627
-3% -$4.26M 0.07% 276
2015
Q4
$223M Buy
1,774,121
+4,715
+0.3% +$593K 0.11% 168
2015
Q3
$184M Buy
1,769,406
+124,052
+8% +$12.9M 0.1% 201
2015
Q2
$203M Buy
1,645,354
+49,305
+3% +$6.09M 0.1% 195
2015
Q1
$188M Sell
1,596,049
-15,131
-0.9% -$1.79M 0.09% 219
2014
Q4
$191M Buy
1,611,180
+70,910
+5% +$8.42M 0.1% 200
2014
Q3
$173M Sell
1,540,270
-1,540,270
-50% -$173M 0.09% 211
2014
Q2
$292M Buy
3,080,540
+1,547,708
+101% +$147M 0.08% 238
2014
Q1
$108M Hold
1,532,832
0.06% 301
2013
Q4
$114M Sell
1,532,832
-371,911
-20% -$27.6M 0.07% 287
2013
Q3
$144M Buy
1,904,743
+1,037,398
+120% +$78.7M 0.08% 232
2013
Q2
$69.3M Buy
+867,345
New +$69.3M 0.04% 406